ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      56,967.44
      0.56%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Regulus Therapeutics Inc (RGLS)

      7. Regulus Therapeutics Inc (RGLS) News

      RGLS

      Regulus Therapeutics (RGLS)

      Regulus Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:RGLS
      DateTimeSourceHeadlineSymbolCompany
      03/07/20142:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RGLSRegulus Therapeutics Inc
      03/07/20142:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RGLSRegulus Therapeutics Inc
      03/05/20148:00AMPR Newswire (US)Regulus Commences Dosing RG-101 in Healthy Volunteers in Phase I StudyNASDAQ:RGLSRegulus Therapeutics Inc
      03/04/20146:10AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:RGLSRegulus Therapeutics Inc
      03/04/20146:08AMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:RGLSRegulus Therapeutics Inc
      02/27/20144:05PMPR Newswire (US)Regulus Provides Strategic Update and Reports Fourth Quarter and Year-End 2013 Financial Results and Recent HighlightsNASDAQ:RGLSRegulus Therapeutics Inc
      02/26/20144:05PMPR Newswire (US)Regulus to Present at Cowen and Company 34th Annual Healthcare ConferenceNASDAQ:RGLSRegulus Therapeutics Inc
      02/20/20144:05PMPR Newswire (US)Regulus Announces Timing for Fourth Quarter and Year-End 2013 Financial Results Webcast and Conference CallNASDAQ:RGLSRegulus Therapeutics Inc
      02/19/20148:00AMPR Newswire (US)Regulus Advances Orphan Disease Portfolio with Nomination of RG-012 as Clinical Development Candidate for the Treatment of Al...NASDAQ:RGLSRegulus Therapeutics Inc
      02/14/20144:44PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RGLSRegulus Therapeutics Inc
      02/14/20142:16PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RGLSRegulus Therapeutics Inc
      02/14/20146:57AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RGLSRegulus Therapeutics Inc
      02/13/20148:00AMPR Newswire (US)Regulus Appoints Head of Regulus microMarkers™ R&D DivisionNASDAQ:RGLSRegulus Therapeutics Inc
      02/07/20143:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RGLSRegulus Therapeutics Inc
      02/07/20143:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RGLSRegulus Therapeutics Inc
      02/06/20143:29PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:RGLSRegulus Therapeutics Inc
      02/05/20143:40PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RGLSRegulus Therapeutics Inc
      02/05/20143:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RGLSRegulus Therapeutics Inc
      02/05/201411:08AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RGLSRegulus Therapeutics Inc
      02/05/20148:00AMPR Newswire (US)Regulus Renews Strategic Alliance with Sanofi to Focus on Orphan Disease and Oncology Targets and Receives Additional $10 Mil...NASDAQ:RGLSRegulus Therapeutics Inc
      02/04/20148:00AMPR Newswire (US)Regulus Strengthens Executive Management Team with Addition of David Szekeres as Chief Business Officer and General CounselNASDAQ:RGLSRegulus Therapeutics Inc
      02/03/20144:05PMPR Newswire (US)Regulus to Present at Two Upcoming Investor ConferencesNASDAQ:RGLSRegulus Therapeutics Inc
      01/13/20148:00AMPR Newswire (US)Regulus Expands its Biomarkers Platform and Establishes Regulus microMarkers™, a New R&D Division Focused on Identifying mi...NASDAQ:RGLSRegulus Therapeutics Inc
      01/07/20144:05PMPR Newswire (US)Regulus to Present at 32nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RGLSRegulus Therapeutics Inc
      12/23/20138:00AMPR Newswire (US)Regulus Announces Addition to NASDAQ Biotechnology IndexNASDAQ:RGLSRegulus Therapeutics Inc
      11/20/20138:00AMPR Newswire (US)Regulus Demonstrates Initial Progress in microRNA Biomarkers MS Collaboration and Receives Milestone Payment from Biogen IdecNASDAQ:RGLSRegulus Therapeutics Inc
      11/13/20134:39PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RGLSRegulus Therapeutics Inc
      11/13/20134:05PMPR Newswire (US)Regulus Reports Third Quarter 2013 Financial Results and Recent HighlightsNASDAQ:RGLSRegulus Therapeutics Inc
      11/08/201310:00AMPR Newswire (US)Regulus Presents Positive Preclinical Data Demonstrating that microRNA-21 Plays an Important Role in Alport SyndromeNASDAQ:RGLSRegulus Therapeutics Inc
      11/06/20134:05PMPR Newswire (US)Regulus Announces Timing for Third Quarter 2013 Financial Results Webcast and Conference CallNASDAQ:RGLSRegulus Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:RGLS